Last $8.14 USD
Change Today -0.12 / -1.45%
Volume 85.0K
CCXI On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas J. Schall Ph.D.

Founder, Chairman, Chief Executive Officer and President, ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Thomas J. Schall, Ph.D. founded ChemoCentryx Inc. in November 1996 and has been its Chief Executive Officer and President since November 1996. Dr. Schall focuses on the discovery and development of chemokine-based therapeutics widely regarded as a Leader in chemokine research, his laboratories have been responsible for the discovery or co-discovery of almost one-third of all known chemokine receptors. From December 1993 to November 1996, he worked at the DNAX ResearchInstitute, ...

Read Full Background

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

Founder, Chairman, Chief Executive Officer and President


Stanford University
Northern Illinois University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$510,000

Stock Options*

All Other Compensation$690
Exercisable Options1,341,697
Unexercisable Options547,557
Total Number of Options1,889,254

Total Compensation*

Total Annual Cash Compensation$721,065
Total Short Term Compensation$510,000
Other Long Term Compensation$690
Total Calculated Compensation$2,315,889
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $8.14 USD -0.12


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
Herve Hoppenot Chief Executive Officer, President and Director
Incyte Corporation
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at